Startup firm seeks clinical trials in U.S for brain surgery material

Local startup company Taiwan Biomaterial Co. (TWBM) said Tuesday it is planning to apply to the Food and Drug Administration in the United States to conduct clinical trials for its globally patented brain surgery material "Foamagen."

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)